Home
Browse All Titles
Sign In
Browse All Titles
The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs
About
Table of Contents
Main Index
Figure(s)
Table(s)
Box(es)
Flowchart(s)
Medication Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com:11002
◀
A
B
C
D
E
I
L
M
O
P
S
T
V
W
▶
View All
Adverse Effects of Antidepressants Reported by 1.
Adverse Effects of Benzodiazepines
An Example Reduction Schedule for Sertraline Consisting of 5 Percentage Point Reductions
Applicability of Different Options for Sertraline.
Barriers and Facilitators for Patients to Stop Antidepressants
Barriers and Facilitators for Patients to Stop Benzodiazepines and Z-Drugs
Barriers and Facilitators for Patients to Stop Psychiatric Medications
Benzodiazepine Withdrawal Symptoms - Overlapping with Anxiety Disorders and More Distinctive Symptoms
Common Antidepressants Stratified by Risk of Withdrawal Symptoms.
Conditions for Which Antidepressant Withdrawal Symptoms are Mis-Diagnosed
Distinguishing Features Between Antidepressant Withdrawal Symptoms and Relapse of an Underlying Condition
Distinguishing Features Between Psychiatric Drug Withdrawal Symptoms and Relapse of an Underlying Condition
Dose Equivalencies Between Benzodiazepines.
Doses of Diazepam Required to Produce Reductions in Effect at the Gabaa Receptor of 5 Percentage Points.
Estimation of Risk Category for Withdrawal for an Individual Patient.
Estimation of Tapering Rate Based on Risk of Withdrawal Symptoms (See Table(s) 2.
Incidence of Withdrawal in Double-Blind Randomised Controlled Trials Captured in Davies and Read (2019)
Licensed Indications and Unlicensed Uses for Gabapentinoids in the USA and Uk
Longer-Term Use or Relapse Prevention Advice in Official Guidelines
Manufacturer's Liquid and Dispersible Tablet Formulations Available for the 10 Most Commonly Used Antidepressants in the Uk for 2017-2018.
Most Commonly Reported Symptoms of 1.
Most Discriminatory Withdrawal Symptoms, in Order
Options Available for Making Up Small Dosage Forms of Antidepressants in the USA
Potential Mis-Diagnoses of Drug Withdrawal Syndromes
Preliminary Tool for Evaluation of Risk of Withdrawal for an Individual Patient.
Proportion of Patients Able to Discontinue Antidepressants in Given Timescale of Different Randomised Controlled Trials
SERT Occupancy Produced by Linear Reductions of Sertraline and the Change in SERT Produced by Each Step
Tablet and Liquid Formulations Available for Commonly Used Benzodiazepines and Z-Drugs.
The Relationship Between Dosage of Antidepressants and Incidence of Withdrawal Effects
The Relationship Between Duration of Treatment and Duration of Withdrawal Effects of Studies Included in the 2019 Systematic Review
Refresh
first
prev
1
2
30
select
next
last
Displaying items 1 - 30 of 36